The Cooper Companies, Inc.

(NASDAQ Global Select)
Back to all articles
Somewhat Bullish +50

The Cooper Companies: Fiscal Q2 Earnings Snapshot

AI-generated analysis

πŸ“‰ The Cooper Companies reported a fiscal Q2 loss of $77.9 million, translating to a 40-cent per-share loss.

πŸ’° Adjusted earnings for one-time items came in at $1.21 per share, surpassing analyst estimates of $1.10.

πŸ“ˆ Revenue reached $1.08 billion during the quarter, exceeding the Street forecast of $1.05 billion.

πŸ”­ The company projects full-year earnings between $4.58 and $4.66 per share.

πŸ’΅ Full-year revenue is expected to fall within the range of $4.29 billion to $4.32 billion.

🏒 The San Ramon, California-based manufacturer produces surgical and contact lens products.

πŸ“Š Results were based on data from Zacks Investment Research and beat expectations from six surveyed analysts.

Bullish Signals
  • The Cooper Companies reported adjusted earnings of $1.21 per share, surpassing the average analyst estimate of $1.10 per share.
  • Revenue reached $1.08 billion in fiscal Q2, exceeding Wall Street forecasts which anticipated $1.05 billion.
  • The company's full-year guidance remains strong with expected earnings between $4.58 and $4.66 per share.
  • Full-year revenue guidance is set at a range of $4.29 billion to $4.32 billion, indicating sustained demand for surgical and contact lens products.
Risk Factors
  • The company reported a fiscal second-quarter loss of $77.9 million, or 40 cents per share.
Full Analysis
The Cooper Companies reported a fiscal second-quarter loss of $77.9 million, or 40 cents per share, though adjusted earnings came to $1.21 per share after accounting for one-time gains and costs. These results exceeded Wall Street expectations, with the average analyst estimate from Zacks Investment Research projecting earnings of $1.10 per share. Revenue for the period reached $1.08 billion, surpassing the consensus forecast of $1.05 billion among six surveyed analysts. Looking ahead, The Cooper Companies expects full-year earnings to fall between $4.58 and $4.66 per share, with revenue anticipated in the range of $4.29 billion to $4.32 billion. The company manufactures surgical and contact lens products and is based in San Ramon, California. This story was generated by Automated Insights using data from Zacks Investment Research.